Cerenome, Inc. (CNSY) vs Tempest Therapeutics, Inc. (TPST)
Cerenome, Inc. and Tempest Therapeutics, Inc. are both Biotechnology companies. Cerenome, Inc. and Tempest Therapeutics, Inc. are of similar size ($14.4M and $14.3M). Cerenome, Inc. grew revenue faster over the last twelve months: −21.0% against −53.0%. Tempest Therapeutics, Inc. has the higher net margin (0.00% vs −526.5%) and the higher return on invested capital (0.00% vs −532.8%). Across the 15 metrics below, Cerenome, Inc. leads on 9 and Tempest Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | CNSY | TPST | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | (628.12%) | 0.00% | 0.00% |
| Net margin | (526.48%) | 0.00% | 0.00% |
| Free cash flow margin | (560.29%) | 0.00% | 0.00% |
| Return on equity | (520.84%) | (931.14%) | (57.72%) |
| Return on assets | (181.53%) | (237.25%) | (49.22%) |
| Return on invested capital | (532.77%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack